BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33448852
Number of visits today
5040
Number of downloads
16634015
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Meng F, Wang J, Yeo Y. Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy. J Control Release 2022;345:586-600. [PMID: 35351528 DOI: 10.1016/j.jconrel.2022.03.045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y. Nanotechnology for next-generation cancer immunotherapy: State of the art and future perspectives. J Control Release 2023;356:14-25. [PMID: 36805873 DOI: 10.1016/j.jconrel.2023.02.016] [Reference Citation Analysis]
2 Kalita T, Dezfouli SA, Pandey LM, Uludag H. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases. Pharmaceutics 2022;14. [PMID: 36432711 DOI: 10.3390/pharmaceutics14112520] [Reference Citation Analysis]
3 Nedorezova DD, Dubovichenko MV, Belyaeva EP, Grigorieva ED, Peresadina AV, Kolpashchikov DM. Specificity of oligonucleotide gene therapy (OGT) agents. Theranostics 2022;12:7132-57. [PMID: 36276652 DOI: 10.7150/thno.77830] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345